Patent ID: 8129417
Filing Date: 2012-03-06
Classification: A61P,C07D

Abstract:
1. A compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein L R L L R L m and p, at each occurrence, are each independently 1, 2, 3, 4, 5, or 6; n and q, at each occurrence, are each independently 1, 2, 3, 4, or 5; R R R G R R R R with the proviso that L and with the proviso that when L and with the further proviso that the compound is other than: N-(2-trityloctahydrocyclopenta[c]pyrrol-4-yl)acetamide; N-(octahydrocyclopenta[c]pyrrol-4-yl)acetamide-N-methyl-N-(2-trityloctahydrocyclopenta[c]pyrrol-4-yl)acetamide; N-methyl-N-(octahydrocyclopenta[c]pyrrol-4-yl)acetamide; 6-(2-(2-(3-fluoro-6-methoxy-1,5-naphthyridin-4-yl)ethyl)octahydrocyclopenta[c]pyrrol-4-ylamino)methyl-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; tert-butyl 2-(2-(3-fluoro-6-methoxy-1,5-naphthyridin-4-yl)ethyl)octahydrocyclopenta[c]pyrrol-4-ylcarbamate; tert-butyl 2-benzyl octahydrocyclopenta[c]pyrrol-4-ylcarbamate; or tert-butyl octahydrocyclopenta[c]pyrrol-4-ylcarbamate.